Skip to main content

Table 1 Baseline demographic, clinical and serological characteristics of the 192 patients with undifferentiated arthritis

From: Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study

Characteristics

Baseline values

Percent patients

Age, years, mean ± SD

52 ± 16

na

Female, n

147

76.6

Monoarthritis, n

18

9.4

Oligoarthritis, n

57

29.7

Polyarthritis, n

117

60.9

Arthritis of hand joints, n

126

65.6

CRP

  

   Positive, n

98

51.0

   Ratio, median (IR)

1.1 (0.6-4.1)

na

ESR

  

   Increased, n

103

53.6

   Ratio, median (IR)

22.5 (14-40)

na

Rheumatoid factor

  

   Positive

79

(41.4)

   Ratio, median (IR)

0.7 (0.5-3.9)

na

   Low titer on total positive

26

(32.9)

   High titer on total positive

53

(67.1)

ACPA

  

   Positive, n

80

(41.7)

   Ratio, median (IR)

0.5 (0.3-7.8)

na

   Low levels on total positive, n

13

(16.2)

   High levels on total positive, n

67

(83.8)

Baseline therapy

  

   None, n

88

(45.8)

   NSAIDs/Coxibs, n

66

(34.4)

   Corticosteroids, n

10

(5.2)

  1. n, number of patients; CRP, C-reactive protein; IR, interquartile range; ESR, erythrocyte sedimentation rate; ACPA, anti-citrullinated peptide antibodies; NSAID, non-steroidal anti-inflammatory drug; Coxib, Cox-2 selective inhibitor; na, not applicable.